Diagnosis and treatment for Chlamydia tracho- matis infection in female genital tract.

WANG Chen; XUE Feng-xia; HAN Cha.

doi:10.7504/fk2014080104

Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (9) : 666-669. DOI: 10.7504/fk2014080104

WANG Chen,XUE Feng-xia,HAN Cha.

Author information +

History +

Abstract

Abstract: Chlamydia trachomatis infection is one of the most common sexually transmitted diseases in the world，which is mainly diagnosed according to laboratory tests.A substantial proportion of initial infections in both men and women are asymptomatic，and moreover female persistent infections or reinfections usually lead to severe complications.So early diagnosis，timely and effective standardized treatment，and regular follow-up may mean a great significance to patients.Recently，both development in nucleic acid amplification-based diagnostic tests and improvement in collecting specimens greatly promote the Chlamydia trachomatis infections screening.Currently the best public health interventions to prevent infections are to increase screening rates as well as actively provide treatment for patients，without ignoring the sexual health educations-based primary prevention.

Key words

Chlamydia trachomatis / female genital tract / infection

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Chen,XUE Feng-xia,HAN Cha.. Diagnosis and treatment for Chlamydia tracho- matis infection in female genital tract.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2014, 30(9): 666-669 https://doi.org/10.7504/fk2014080104

References

［1］   Geneva: World Health Organization; 2011.Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates.

［2］   郑冰洁,尹跃平.泌尿生殖道沙眼衣原体感染的流行病学进展［J］.国际皮肤性病学杂志，2011，3:183-186.

［3］   Malhotra M，Sood S，Mukherjee A，et al.Genital Chlamydia trachomatis: an update［J］.Indian J Med Res，2013,138(3):303-316.

［4］   Centers for Disease Control and Prevention.Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae，2014［J］.MMWR Recommendations and Reports，2014,63( RR-2):1-14.

［5］   Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines，2010［J］.MMWR Recommendations and Reports,2010,59(RR-12) :1-110.

［6］    刘朝晖,薛凤霞.黏液脓性宫颈炎的诊断和治疗［J］.中国实用妇科与产科杂志,2012,4:241-242.

［7］    Mourad A，Sweet RL，Sugg N，et al.Relative resistance to erythromycin in Chlamydia trachomatis［J］.Antimicrob Agents Chemother，1980,18(5):696-698.

［8］    Jones RB，Van der Pol B，Johnson RB.Susceptibility of Chlamydia trachomatis to trovafloxacin［J］.J Antimicrob Chemother，1997,39（Suppl B）:63-65.

［9］    Somani J，Bhullar VB，Workowski KA，et al.Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure［J］.J Infect Dis，2000,181(4):1421-1427.

［10］   Gomberg MA.Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa ［J］.Antibiot Khimioter，2002,47(5):12-15.

［11］   American College of Obstetricians and Gynecologists.ACOG Practice Bulletin No.121.Long-acting reversible contraception: Implants and intrauterine devices［J］.Obstet Gynecol，2011,118(1):184-196.

［12］    Caddy S，Yudin MH，Hakim J，et al.Best practices to minimize risk of infection with intrauterine device Insertion［J］.J Obstet Gynaecol Can，2014,36(3):266-276.

［13］    Hocking JS，Guy R，Walker J，et al.Advances in sampling and screening for chlamydia［J］.Future Microbiol，2013,8(3):367-386.

（2014-05-26收稿）